Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Bullboard Posts
Comment by rjc7on Mar 12, 2015 8:13am
127 Views
Post# 23512704

RE:RE:RE:RE:100,000 Asking 0.52

RE:RE:RE:RE:100,000 Asking 0.52The selling will subside by the end of March. Any options not yet exercised will then expire.  Some may exercise with their own cash and not sell shares to do it.  Options are a way of life for MBX in their long-term financing, and there is nothing we can do to change it. On the plus side, granting of options eliminates most of our need for bank loans. We really have very little debt. And without options, we would not have been able to finance any of our pipeline products. All he would have at this point, would be the core business and a "wish list" of pipeline products that we could not execute due to lack of cash. Once we find a partner for Luna sort, or urokinase, or start reporting sales on MDx things will look much better. We are not quite at that stage yet. We need a couple partners. I know they are working on it and we must be close.
Bullboard Posts